Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects

被引：17

作者：

Howles, Sarah ^{[1
]}

Guimaraes-Walker, Ana ^{[1
]}

Yang, Hongbing ^{[1
]}

Hancock, Gemma ^{[1
,2
]}

di Gleria, Katalin ^{[1
]}

Tarragona-Fiol, Tony ^{[3
]}

Hayes, Peter ^{[3
]}

Gilmour, Jill ^{[3
]}

Bridgeman, Anne ^{[1
]}

Hanke, Tomas ^{[1
]}

McMichael, Andrew ^{[1
,2
]}

Dorrell, Lucy ^{[1
,2
]}

机构：

[1] John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England

[2] John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Weatherall Inst Mol Med, Oxford OX3 9DS, England

[3] Univ London Imperial Coll Sci Technol & Med, IAVI Core Lab, Chelsea & Westminster Hosp, London SW10 9NH, England

来源：

VACCINE | 2010年 / 28卷 / 45期

基金：

英国医学研究理事会;

关键词：

HIV-1; vaccine; Modified vaccinia virus Ankara (MVA); T cell; Human; Clinical trial; THERAPEUTIC VACCINATION; ANTIRETROVIRAL THERAPY; TYPE-1; CLADE; EPITOPES; GAG; DNA; SMALLPOX; SAFETY; MVA; IMMUNODOMINANCE;

D O I：

10.1016/j.vaccine.2010.08.077

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated whether vaccination of healthy HIV-seronegative and HIV-1-seropositive antiretroviral therapy-treated subjects with recombinant modified vaccinia virus Ankara expressing an HIV-1 immunogen (MVA.HIVA) induced MVA-specific T cell responses. Using IFN-gamma Elispot assays, we observed new or increased responses to MVA virus in 52% of HIV-seronegative subjects and 93% HIV-1 seropositive subjects; MVA-specific T cell frequencies were generally low and correlated poorly with T cell responses to the HIV-1 immunogen. In two vaccinees, responses were mapped to CD8+ T cell epitopes present in replication-competent vaccinia virus. These data support further evaluation of MVA as a viral vector for HIV-1 immunogens. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7306 / 7312

页数：7

共 50 条

[1] Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus
Perdiguero, Beatriz
Sanchez-Corzo, Cristina
Sorzano, Carlos Oscar S.
Mediavilla, Pilar
Saiz, Lidia
Esteban, Mariano
Elena Gomez, Carmen
VACCINES, 2019, 7 (03)
[2] Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
Wilken, Lucas
Stelz, Sonja
Agac, Ayse
Sutter, Gerd
Prajeeth, Chittappen Kandiyil
Rimmelzwaan, Guus F.
VACCINES, 2023, 11 (04)
[3] HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
Shen, Xiaoying
Basu, Rahul
Sawant, Sheetal
Beaumont, David
Kwa, Sue Fen
LaBranche, Celia
Seaton, Kelly E.
Yates, Nicole L.
Montefiori, David C.
Ferrari, Guido
Wyatt, Linda S.
Moss, Bernard
Alam, S. Munir
Haynes, Barton F.
Tomaras, Georgia D.
Robinson, Harriet L.
JOURNAL OF VIROLOGY, 2017, 91 (24)
[4] Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses
Ondondo, Beatrice O.
Yang, Hongbing
Dong, Tao
di Gleria, Kati
Suttill, Annie
Conlon, Christopher
Brown, Denise
Williams, Patricia
Rowland-Jones, Sarah L.
Hanke, Tomas
McMichael, Andrew J.
Dorrell, Lucy
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (10) : 2585 - 2594
[5] Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy
Dorrell, Lucy
Williams, Patricia
Suttill, Annie
Brown, Denise
Roberts, Joanna
Conlon, Christopher
Hanke, Tomas
McMichael, Andrew
VACCINE, 2007, 25 (17) : 3277 - 3283
[6] Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-γ ELISPOT assay
Winstone, Nicola
Guimaraes-Walker, Ana
Roberts, Joanna
Brown, Denise
Loach, Vanessa
Goonetilleke, Nilu
Hanke, Tomas
McMichael, Andrew J.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (04) : 975 - 985
[7] Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination
Rallon, Norma
Mothe, Beatriz
Lopez Bernaldo de Quiros, Juan C.
Plana, Montserrat
Ligos, Jose M.
Montoya, Maria
Munoz-Fernandez, Maria A.
Esteban, Mariano
Garcia, Felipe
Brander, Christian
Benito, Jose M.
AIDS, 2016, 30 (04) : 553 - 562
[8] First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Baden, Lindsey R.
Walsh, Stephen R.
Seaman, Michael S.
Cohen, Yehuda Z.
Johnson, Jennifer A.
Licona, J. Humberto
Filter, Rachel D.
Kleinjan, Jane A.
Gothing, Jon A.
Jennings, Julia
Peter, Lauren
Nkolola, Joseph
Abbink, Peter
Borducchi, Erica N.
Kirilova, Marinela
Stephenson, Kathryn E.
Pegu, Poonam
Eller, Michael A.
Trinh, Hung V.
Rao, Mangala
Ake, Julie A.
Sarnecki, Michal
Nijs, Steven
Callewaert, Katleen
Schuitemaker, Hanneke
Hendriks, Jenny
Pau, Maria G.
Tomaka, Frank
Korber, Bette T.
Alter, Galit
Dolin, Raphael
Earl, Patricia L.
Moss, Bernard
Michael, Nelson L.
Robb, Merlin L.
Barouch, Dan H.
JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (04) : 633 - 644
[9] Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen
Jones, Dorothy, I
Pollara, Justin J.
Johnson-Weaver, Brandi T.
LaBranche, Celia C.
Montefiori, David C.
Pickup, David J.
Permar, Sallie R.
Abraham, Soman N.
Maddaloni, Massimo
Pascual, David W.
Staats, Herman F.
JOURNAL OF VIROLOGY, 2019, 93 (14)
[10] Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion
Song, Guang-Yun
Srivastava, Tumul
Ishizaki, Hidenobu
Lacey, Simon F.
Diamond, Don J.
Ellenhorn, Joshua D. I.
CANCER INVESTIGATION, 2011, 29 (08) : 501 - 510

← 1 2 3 4 5 →